Clinical Trial Update: Safety and Efficacy of G-Pen Compared to Lilly Glucagon for Hypoglycemia Rescue in Adult Type 1 Diabetics [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing G-Pen to Lilly Glucagon for hypoglycemia rescue in adults with Type 1 diabetes has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoglycemia
• Type 1 Diabetes Mellitus

Drugs mentioned

• G-Pen (glucagon)
• Lilly Glucagon (glucagon)

Snippet

Sponsor: Xeris Pharmaceuticals | Conditions: Hypoglycemia, Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED | Results posted: 2018-09-28